Nicholas N. Vahanian - Net Worth and Insider Trading

Nicholas N. Vahanian Net Worth

The estimated net worth of Nicholas N. Vahanian is at least $20,384 dollars as of 2024-04-23. Nicholas N. Vahanian is the President, Chief Medical Offic of Lumos Pharma Inc and owns about 7,254 shares of Lumos Pharma Inc (LUMO) stock worth over $20,384. Details can be seen in Nicholas N. Vahanian's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nicholas N. Vahanian has not made any transactions after 2016-01-05 and currently still holds the listed stock(s).

Transaction Summary of Nicholas N. Vahanian

Nicholas N. Vahanian Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nicholas N. Vahanian owns 1 companies in total, including Lumos Pharma Inc (LUMO) .

Click here to see the complete history of Nicholas N. Vahanian’s form 4 insider trades.

Insider Ownership Summary of Nicholas N. Vahanian

Ticker	Comapny	Transaction Date	Type of Owner
LUMO	Lumos Pharma Inc	2016-01-05	President & Chief Medical Offic

Nicholas N. Vahanian Latest Holdings Summary

Nicholas N. Vahanian currently owns a total of 1 stock. Nicholas N. Vahanian owns 7,254 shares of Lumos Pharma Inc (LUMO) as of January 5, 2016, with a value of $20,384.

Latest Holdings of Nicholas N. Vahanian

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
LUMO	Lumos Pharma Inc	2016-01-05	7,254	2.81	20,384

Holding Weightings of Nicholas N. Vahanian

Nicholas N. Vahanian Form 4 Trading Tracker

According to the SEC Form 4 filings, Nicholas N. Vahanian has made a total of 0 transactions in Lumos Pharma Inc (LUMO) over the past 5 years. The most-recent trade in Lumos Pharma Inc is the sale of 335 shares on January 5, 2016, which brought Nicholas N. Vahanian around $105,566.

Insider Trading History of Nicholas N. Vahanian

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nicholas N. Vahanian Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nicholas N. Vahanian Ownership Network

Ownership Network List of Nicholas N. Vahanian

No Data

Ownership Network Relation of Nicholas N. Vahanian

Nicholas N. Vahanian Owned Company Details

What does Lumos Pharma Inc do?

Who are the key executives at Lumos Pharma Inc?

Nicholas N. Vahanian is the President & Chief Medical Offic of Lumos Pharma Inc. Other key executives at Lumos Pharma Inc include Chief Medical Officer David B Karpf , Chief Business Officer Aaron Schuchart , and 10 percent owner & other: Possible Member of 10% Group James E Flynn .

Lumos Pharma Inc (LUMO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Lumos Pharma Inc (LUMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lumos Pharma Inc (LUMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Lumos Pharma Inc (LUMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lumos Pharma Inc Insider Transactions

No Available Data

Nicholas N. Vahanian Mailing Address

Above is the net worth, insider trading, and ownership report for Nicholas N. Vahanian. You might contact Nicholas N. Vahanian via mailing address: C/o Newlink Genetics Corp., 2503 South Loop Dr., Suite 5100, Aimes Ia 50010.

Discussions on Nicholas N. Vahanian

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.